Attend the FierceBiotech 3rd Drug Development Forum!
The leading executive-level forum for biotech strategy & networking | Oct 1-3 | Boston
It can be seriously disruptive when the site investigator for your trial leaves or decides to step down, but new recommendations from the Clinical Trials…
PSI has opened an office in Taipei, making it its third new establishment set up this year in the Asia-Pacific region.
Antidote, which develops an online platform to match patients with researchers, just raised $11 million backed by Merck's GHI fund.
Machine learning-focused software company Teckro has raised $10 million in series B financing to advance its clinical trial digital platform.
A nonprofit CRO formed by several ex-DuPont scientists will start operating at a new lab on Oct.1.
Parexel says it has delivered revenue “beyond expectation” in one of its last financials before being merged into Pamplona Capital Management.
Nonclinical service CRO Envigo is merging with publicly traded Avista Healthcare Public Acquisition Corporation.
Charles River Laboratories is buying CRO Brains On-Line for €18 million as it further strengthens its offers in CNS early-stage drug research.
PRA will buy health data and analytics expert Symphony Health for $530 million up front as it reports 16% second-quarter service revenue growth.
Icon strengthens real-world evidence offerings by acquiring health research and commercialization company Mapi.